Funding Rounds
Nucleome Therapeutics

Nucleome Therapeutics Unknown (2022, $43M)

Nucleome Therapeutics

Platform focused on decoding the dark matter of the human genome to discover new treatments for diseases.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $43.51M

Raised Date: 2022-01-01